Blakely Tony, Cobiac Linda J, Cleghorn Christine L, Pearson Amber L, van der Deen Frederieke S, Kvizhinadze Giorgi, Nghiem Nhung, McLeod Melissa, Wilson Nick
Burden of Disease Epidemiology, Equity and Cost Effectiveness Programme, Department of Public Health, University of Otago, Wellington, New Zealand.
Burden of Disease Epidemiology, Equity and Cost Effectiveness Programme, Department of Public Health, University of Otago, Wellington, New Zealand; British Heart Foundation Centre on Population Approaches to NCD Prevention, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
PLoS Med. 2015 Jul 28;12(7):e1001856. doi: 10.1371/journal.pmed.1001856. eCollection 2015 Jul.
Countries are increasingly considering how to reduce or even end tobacco consumption, and raising tobacco taxes is a potential strategy to achieve these goals. We estimated the impacts on health, health inequalities, and health system costs of ongoing tobacco tax increases (10% annually from 2011 to 2031, compared to no tax increases from 2011 ["business as usual," BAU]), in a country (New Zealand) with large ethnic inequalities in smoking-related and noncommunicable disease (NCD) burden.
We modeled 16 tobacco-related diseases in parallel, using rich national data by sex, age, and ethnicity, to estimate undiscounted quality-adjusted life-years (QALYs) gained and net health system costs over the remaining life of the 2011 population (n = 4.4 million). A total of 260,000 (95% uncertainty interval [UI]: 155,000-419,000) QALYs were gained among the 2011 cohort exposed to annual tobacco tax increases, compared to BAU, and cost savings were US$2,550 million (95% UI: US$1,480 to US$4,000). QALY gains and cost savings took 50 y to peak, owing to such factors as the price sensitivity of youth and young adult smokers. The QALY gains per capita were 3.7 times greater for Māori (indigenous population) compared to non-Māori because of higher background smoking prevalence and price sensitivity in Māori. Health inequalities measured by differences in 45+ y-old standardized mortality rates between Māori and non-Māori were projected to be 2.31% (95% UI: 1.49% to 3.41%) less in 2041 with ongoing tax rises, compared to BAU. Percentage reductions in inequalities in 2041 were maximal for 45-64-y-old women (3.01%). As with all such modeling, there were limitations pertaining to the model structure and input parameters.
Ongoing tobacco tax increases deliver sizeable health gains and health sector cost savings and are likely to reduce health inequalities. However, if policy makers are to achieve more rapid reductions in the NCD burden and health inequalities, they will also need to complement tobacco tax increases with additional tobacco control interventions focused on cessation.
各国越来越多地考虑如何减少甚至消除烟草消费,提高烟草税是实现这些目标的一项潜在策略。在一个吸烟相关疾病和非传染性疾病(NCD)负担存在巨大种族不平等的国家(新西兰),我们估计了持续提高烟草税(2011年至2031年每年提高10%,与2011年不提高税收的情况[“照常营业”,BAU]相比)对健康、健康不平等和卫生系统成本的影响。
我们同时对16种与烟草相关的疾病进行建模,使用按性别、年龄和种族分类的丰富国家数据,以估计2011年人口(n = 440万)剩余寿命期间获得的未贴现质量调整生命年(QALY)以及卫生系统净成本。与BAU相比,在2011年队列中,每年提高烟草税的人群共获得260,000(95%不确定区间[UI]:155,000 - 419,000)个QALY,成本节省25.5亿美元(95% UI:14.8亿美元至40亿美元)。由于青年和年轻成年吸烟者的价格敏感性等因素,QALY的增加和成本节省需要50年才能达到峰值。毛利人(原住民)人均获得的QALY是非毛利人的3.7倍,因为毛利人的背景吸烟率较高且价格敏感性较高。预计到2041年,与BAU相比,持续提高税收的情况下,毛利人和非毛利人45岁及以上标准化死亡率差异所衡量的健康不平等将减少2.31%(95% UI:1.49%至3.41%)。2041年,45 - 64岁女性的不平等减少百分比最大(3.01%)。与所有此类建模一样,该模型在结构和输入参数方面存在局限性。
持续提高烟草税可带来可观的健康收益和卫生部门成本节省,并可能减少健康不平等。然而,如果政策制定者要更快地减少非传染性疾病负担和健康不平等,他们还需要通过侧重于戒烟的额外烟草控制干预措施来补充提高烟草税的举措。